Literature DB >> 19561850

Administration of proton pump inhibitors in patients requiring enteral nutrition.

Terri M Wensel1.   

Abstract

Entities:  

Keywords:  administration; enteral; proton pump inhibitor

Year:  2009        PMID： 19561850      PMCID： PMC2697083     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  20 in total

1.  Oral bioavailability of pantoprazole suspended in sodium bicarbonate solution.

Authors:  Geraldine M Ferron; Sherry Ku; Madelyn Abell; Mary Unruh; John Getsy; Philip R Mayer; Jeffrey Paul
Journal:  Am J Health Syst Pharm       Date:  2003-07-01       Impact factor: 2.637

2.  Lansoprazole: administration of the contents of a capsule dosage formulation through a nasogastric tube.

Authors:  A H Chun; H H Shi; R Achari; S Dennis; J H Cavanaugh
Journal:  Clin Ther       Date:  1996 Sep-Oct       Impact factor: 3.393

3.  Comparison of the enteral and intravenous lansoprazole pharmacodynamic responses in critically ill patients.

Authors:  K M Olsen; J W Devlin
Journal:  Aliment Pharmacol Ther       Date:  2008-08-01       Impact factor: 8.171

4.  A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers.

Authors:  J O Phillips; K M Olsen; J A Rebuck; N J Rangnekar; B W Miedema; M H Metzler
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

5.  Effects on 24-hour intragastric pH: a comparison of lansoprazole administered nasogastrically in apple juice and pantoprazole administered intravenously.

Authors:  J Freston; Y L Chiu; W J Pan; N Lukasik; J Täubel
Journal:  Am J Gastroenterol       Date:  2001-07       Impact factor: 10.864

6.  Failure of nasogastric omeprazole suspension in pediatric intensive care patients.

Authors:  Julie A Haizlip; Ralph A Lugo; Jared J Cash; Donald D Vernon
Journal:  Pediatr Crit Care Med       Date:  2005-03       Impact factor: 3.624

7.  Comparative pharmacokinetics and pharmacodynamics of lansoprazole oral capsules and suspension in healthy subjects.

Authors:  T T Doan; Q Wang; J S Griffin; N L Lukasik; R F O'Dea; W J Pan
Journal:  Am J Health Syst Pharm       Date:  2001-08-15       Impact factor: 2.637

8.  The effects on intragastric acidity of per-gastrostomy administration of an alkaline suspension of omeprazole.

Authors:  V K Sharma; R Vasudeva; C W Howden
Journal:  Aliment Pharmacol Ther       Date:  1999-08       Impact factor: 8.171

9.  The pharmacodynamics of lansoprazole administered via gastrostomy as intact, non-encapsulated granules.

Authors:  V K Sharma; E A Ugheoke; R Vasudeva; C W Howden
Journal:  Aliment Pharmacol Ther       Date:  1998-11       Impact factor: 8.171

10.  Omeprazole pharmacodynamics and gastric acid suppression in critically ill pediatric transplant patients.

Authors:  K M Olsen; K L Bergman; S S Kaufman; J A Rebuck; D S Collier
Journal:  Pediatr Crit Care Med       Date:  2001-07       Impact factor: 3.624
View more
  7 in total

1.  In Vitro Evaluation of Nasogastric Tube Delivery Performance of Esomeprazole Magnesium Delayed-Release Capsules.

Authors:  Alicia Hoover; Dajun Sun; Hong Wen; Wenlei Jiang; Minglei Cui; Xiaojian Jiang; David Keire; Changning Guo
Journal:  J Pharm Sci       Date:  2017-04-15       Impact factor: 3.534

2.  Reply.

Authors:  Aylin Tansel; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2017-04-15       Impact factor: 11.382

3.  A Critical Assessment of Extemporaneous Formulations for Proton Pump Inhibitors: The Importance of Proper Vehicle Selection.

Authors:  Ognjenka Rahić; Jasmina Hadžiabdić; Amina Tucak; Merima Sirbubalo; Lamija Hindija; Alisa Elezović; Edina Vranić
Journal:  J Pediatr Pharmacol Ther       Date:  2022-09-26

4.  Compatibility of proton pump inhibitors in a preservative-free suspending vehicle.

Authors:  Hudson C Polonini; Sharlene L Silva; Shirley Loures; Rachel Almy; Antoine Balland; Marcos Antônio F Brandão; Anderson O Ferreira
Journal:  Eur J Hosp Pharm       Date:  2016-11-25

5.  The Role of the Pharmacist in Selecting the Best Choice of Medication Formulation in Dysphagic Patients.

Authors:  Guendalina Zuccari; Sara Macis; Silvana Alfei; Leonardo Marchitto; Eleonora Russo
Journal:  J Pers Med       Date:  2022-08-12

6.  Errors of oral medication administration in a patient with enteral feeding tube.

Authors:  Shahram Emami; Hadi Hamishehkar; Ata Mahmoodpoor; Simin Mashayekhi; Parina Asgharian
Journal:  J Res Pharm Pract       Date:  2012-07

7.  Gaps in Accessibility of Pediatric Formulations: A Cross-Sectional Observational Study of a Teaching Hospital in Northern Thailand.

Authors:  Prangthong Tiengkate; Marc Lallemant; Pimlak Charoenkwan; Chaisiri Angkurawaranon; Penkarn Kanjanarat; Puckwipa Suwannaprom; Phetlada Borriharn
Journal:  Children (Basel)       Date:  2022-02-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.